X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Expert Opinion on Drug Delivery

期刊標題檢索 EXPERT OPIN DRU 最新評論: 3-5 recommended journals (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Expert Opinion on Drug Delivery]您好,您是該頁面的第 41182 位訪客。

期刊簡介
期刊名稱Expert Opinion on Drug Delivery Expert Opinion on Drug Delivery
LetPub Score
7.6
50 ratings
Rate

Reputation
8.8

Influence
6.4

Speed
9.0

期刊簡稱EXPERT OPIN DRUG DEL
ISSN1742-5247
h-index88
CiteScore
CiteScoreSJRSNIPCiteScore Rank
11.101.0091.090
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q113 / 183

自引率 (2023-2024)4.00%自引率趨勢
掲載範囲
Expert Opinion on Drug Delivery (ISSN 1742-5247 [print], 1744-7593 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.
官方網站http://www.tandfonline.com/loi/iedd20
在線稿件提交https://mc.manuscriptcentral.com/eodd
開放訪問No
出版商Taylor and Francis Ltd.
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年2004
每年文章數103每年文章數趨勢
黃金OA百分比15.75%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ143/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1742-5247%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Expert Opinion on Drug Delivery】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498579
    PHYTOMEDICINE343291
    LIFE SCIENCES288962
    PHARMACOLOGICAL RESEARCH243023
    International Journal of Pharmaceutics242636
    European Journal of Pharmacology204464
    BIOCHEMICAL PHARMACOLOGY202911
    JOURNAL OF NATURAL PRODUCTS196809
    BRITISH JOURNAL OF PHARMACOLOGY165358
    MOLECULAR PHARMACEUTICS162930
  •  

    Expert Opinion on Drug Delivery Expert Opinion on Drug Delivery
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Expert Opinion on Drug Delivery] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:07:59 評論於
3-5 recommended journals
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:04:52 評論於
Authors should first search and analyze in SCI and Scopus databases. Secondly, they need to carefully read the submission guidelines of the journal they are preparing to submit to, and review the recent issues and related articles of the journal to confirm if their manuscript aligns with the journal's content
(0) 讚! | 维尔娜菲茨杰拉德

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 13:23:41 評論於
How to evaluate the impact factor of your own article, or how to better position your article?
(0) 讚! | 平原文波

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 11:32:45 評論於
How many suitable options are selected when selecting the periodical?
(0) 讚! | 北国博达

作者: 巴蜀清雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-04-21 23:43:25 評論於
Review speed: 4.0 Experience sharing: What to do if the link to the editor's reply cannot be opened Expert opinion on drug delivery
(0) 讚! | 巴蜀清雅

作者: 碧桃逸致


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-04-21 16:27:46 評論於
Review speed: 4.0
Experience sharing: What to do if the URL of the editor's response cannot be opened
Expert opinion on drug delivery
(0) 讚! | 碧桃逸致

作者: 193291787@qq.com


領域: 医药科学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2018-04-21 10:23:29 評論於
Edit reply URL can not open,How to do expert opinion on drug delivery
(0) 讚! | 193291787@qq.com

作者: 193291787@qq.com


領域: 医药科学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2018-04-21 10:23:21 評論於
Edit reply reply URL can not open, how to do expert opinion on drug delivery
(0) 讚! | 193291787@qq.com

作者: 亚当威尔斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-04-13 12:39:37 評論於
Review speed: 2.0
Experience sharing: It took two months to receive a response after submitting the manuscript, and it was still not sent for review. The wait for editor processing also took another two months. The journal mainly publishes review articles. I am not sure if the delay is due to the fact that my article is original research. However, the editor processing is also too slow
(0) 讚! | 亚当威尔斯

作者: 479152268@qq.com


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2018-04-13 09:46:28 評論於
I received the results two months after submission. It was not sent to peer review, so it took two months just waiting for the editorial processing. The journal publishes review articles; I don't know if this is the reason why it took so long. But the editing process is too slow.

(0) 讚! | 479152268@qq.com

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 11:05:03 評論於
It's still just above average, although there hasn't been much change, being able to stay stable is considered above average
(0) 讚! | 凌霄高洁

作者: 金刚爱鹏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-02-01 22:22:23 評論於
Hello, I would like to ask for expert opinion on drug delivery. After submission and successful acceptance, the status is Awaiting Commissioning Editor Processing, and the system sends an email with a PDF attachment, stating "If you have not already done so, please complete and return the attached disclosure form." It then asks to choose the reviewing method and if there is a need for acceleration. Do I need to reply?
(0) 讚! | 金刚爱鹏

作者: 法慧和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-09-01 23:41:00 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0
Experience sharing: Quite difficult, revised many times, also requires high research completeness
(0) 讚! | 法慧和同

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 12:51:19 評論於
Bullish, will it rise again next year?
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Expert Opinion on Drug Delivery] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*